Lenalidomide | List of Frontiers open access articles

Original Research

Published on 09 Nov 2022

The long multi-epitope peptide vaccine combined with adjuvants improved the therapeutic effects in a glioblastoma mouse model

in Cancer Immunity and Immunotherapy

Thi-Anh-Thuy Tran
Young-Hee Kim
Ga-Eun Kim
Shin Jung
In-Young Kim
Kyung-Sub Moon
Young-Jin Kim
Tae-Kyu Lee
Hyosuk Yun
Je-Jung Lee

Frontiers in Immunology

doi 10.3389/fimmu.2022.1007285

5,813 views
6 citations

Original Research

Published on 21 Aug 2018

Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study

in Clinical Nutrition

Tomoki Ito
Akiko Konishi
Yukie Tsubokura
Yoshiko Azuma
Masaaki Hotta
Hideaki Yoshimura
Takahisa Nakanishi
Shinya Fujita
Aya Nakaya
Atsushi Satake

Frontiers in Nutrition

doi 10.3389/fnut.2018.00072

4,588 views
12 citations

Case Report

Published on 16 Jun 2025

Lenalidomide-induced type II Kounis syndrome: a case report

in Coronary Artery Disease

Ruihan Hu
Guoxiang He

Frontiers in Cardiovascular Medicine

doi 10.3389/fcvm.2025.1591179

2,113 views
1 citation

Brief Research Report

Published on 18 Feb 2022

Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis

in Hematologic Malignancies

Hira Mian
Christine Eisfeld
Christopher P. Venner
Esther Masih-Khan
Moustafa Kardjadj
Victor H. Jimenez-Zepeda
Cyrus Khandanpour
Georg Lenz
Arleigh McCurdy
Michael Sebag

Frontiers in Oncology

doi 10.3389/fonc.2022.826342

7,992 views
9 citations

Original Research

Published on 16 Dec 2024

Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China

in Pharmacoepidemiology

Rongqi Li
Yuhan Zeng
Yizhang Chen
Zhongjiang Ye
Chuang Chen
Jianhui Yang
Jing Fu
Tao Zhou
Danna Jiang
Sunting Qin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412743

2,246 views

Review

Published on 23 Sep 2014

PP2A: The Achilles Heal in MDS with 5q Deletion

in Hematologic Malignancies

David A. Sallman
Sheng Wei
Alan List

Frontiers in Oncology

doi 10.3389/fonc.2014.00264

12,639 views
24 citations

Original Research

Published on 28 Jul 2022

Lenalidomide potentially reduced the level of cell- associated HIV RNA and improved persistent inflammation in patients with HIV-associated cryptococcal meningitis a pilot study

in Clinical and Diagnostic Microbiology and Immunology

Xiang Liu
Xueling Zhu
Xiaorong Peng
Ran Tao
Zhikai Wan
Jiangjin Hui
Yongzheng Guo
Ying Hang
Biao Zhu

Frontiers in Cellular and Infection Microbiology

doi 10.3389/fcimb.2022.954814

3,913 views
4 citations

Case Report

Published on 31 Mar 2022

Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series

in Hematologic Malignancies

Anna Stein
Anne Sophie Kubasch
Claudia Haferlach
Uwe Platzbecker

Frontiers in Oncology

doi 10.3389/fonc.2022.866470

3,228 views
2 citations

Case Report

Published on 25 May 2021

PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report

in Cancer Immunity and Immunotherapy

Chenggong Li
Yan Sun
Jing Wang
Lu Tang
Huiwen Jiang
Tao Guo
Lin Liu
Yaohui Wu
Lisha Ai
Linghui Xia

Frontiers in Immunology

doi 10.3389/fimmu.2021.599493

10,148 views
15 citations

Original Research

Published on 13 Jun 2018

Monocyte-Derived Dendritic Cells Differentiated in the Presence of Lenalidomide Display a Semi-Mature Phenotype, Enhanced Phagocytic Capacity, and Th1 Polarization Capability

in Cancer Immunity and Immunotherapy

Juan López-Relaño
Beatriz Martín-Adrados
Irene Real-Arévalo
Javier Lozano-Bartolomé
Beatriz Abós
Silvia Sánchez-Ramón
Bárbara Alonso
Manuel Gómez del Moral
Eduardo Martínez-Naves

Frontiers in Immunology

doi 10.3389/fimmu.2018.01328

12,622 views
17 citations

Mini Review

Published on 07 Mar 2022

Caspase-8: Friend or Foe in Bortezomib/Lenalidomide-Based Therapy for Myeloma

in Molecular and Cellular Oncology

Liang Zhou

Frontiers in Oncology

doi 10.3389/fonc.2022.861709

4,068 views
9 citations

Original Research

Published on 11 Dec 2018

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

in Cancer Immunity and Immunotherapy

Mónica Villa-Álvarez
Christian Sordo-Bahamonde
Seila Lorenzo-Herrero
Ana P. Gonzalez-Rodriguez
Angel R. Payer
Esther Gonzalez-Garcia
María C. Villa-Álvarez
Alejandro López-Soto
Segundo Gonzalez

Frontiers in Immunology

doi 10.3389/fimmu.2018.02917

11,159 views
44 citations

Case Report

Published on 08 Oct 2021

Case Report: Lenalidomide as a Second-Line Treatment for Bortezomib-Ineffective Nephrotic Syndrome Caused by LCDD: 2 Case Reports and a Literature Review

in Nephrology

Xin Zhang
Xiao-juan Yu
Su-xia Wang
Fu-de Zhou
Ming-hui Zhao

Frontiers in Medicine

doi 10.3389/fmed.2021.706971

3,390 views
2 citations

Original Research

Published on 18 Jun 2018

Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma

in Cancer Immunity and Immunotherapy

Manh-Cuong Vo
Sung-Hoon Jung
Tan-Huy Chu
Hyun-Ju Lee
Thangaraj Jaya Lakshmi
Hye-Seong Park
Hyeoung-Joon Kim
Joon Haeng Rhee
Je-Jung Lee

Frontiers in Immunology

doi 10.3389/fimmu.2018.01370

8,704 views
40 citations

Original Research

Published on 21 Jul 2021

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma

in Hematologic Malignancies

Catherine S. Y. Lecat
Jessica B. Taube
William Wilson
Jonathan Carmichael
Christopher Parrish
Gabriel Wallis
Charalampia Kyriakou
Lydia Lee
Shameem Mahmood
Xenofon Papanikolaou

Frontiers in Oncology

doi 10.3389/fonc.2021.703233

8,479 views
20 citations

Systematic Review

Published on 02 Dec 2021

Efficacy and Safety of Lenalidomide Monotherapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis

in Hematologic Malignancies

Jia Li
Jianpeng Zhou
Wei Guo
Xingtong Wang
Yangzhi Zhao
Ou Bai

Frontiers in Oncology

doi 10.3389/fonc.2021.756728

4,348 views
4 citations

Articles

The long multi-epitope peptide vaccine combined with adjuvants improved the therapeutic effects in a glioblastoma mouse model

Combined Use of Ninjin'yoeito Improves Subjective Fatigue Caused by Lenalidomide in Patients With Multiple Myeloma: A Retrospective Study

Lenalidomide-induced type II Kounis syndrome: a case report

Efficacy of Daratumumab-Containing Regimens Among Patients With Multiple Myeloma Progressing on Lenalidomide Maintenance: Retrospective Analysis

Cost-effectiveness analysis of combining lenalidomide with R-CHOP for treating diffuse large B-cell lymphoma in China

PP2A: The Achilles Heal in MDS with 5q Deletion

Lenalidomide potentially reduced the level of cell- associated HIV RNA and improved persistent inflammation in patients with HIV-associated cryptococcal meningitis a pilot study

Case Report: Personalized Therapeutical Approaches with Lenalidomide in Del(5q): A Case Series

PiggyBac-Generated CAR19-T Cells Plus Lenalidomide Cause Durable Complete Remission of Triple-Hit Refractory/Relapsed DLBCL: A Case Report

Monocyte-Derived Dendritic Cells Differentiated in the Presence of Lenalidomide Display a Semi-Mature Phenotype, Enhanced Phagocytic Capacity, and Th1 Polarization Capability

Caspase-8: Friend or Foe in Bortezomib/Lenalidomide-Based Therapy for Myeloma

Ig-Like Transcript 2 (ILT2) Blockade and Lenalidomide Restore NK Cell Function in Chronic Lymphocytic Leukemia

Case Report: Lenalidomide as a Second-Line Treatment for Bortezomib-Ineffective Nephrotic Syndrome Caused by LCDD: 2 Case Reports and a Literature Review

Lenalidomide and Programmed Death-1 Blockade Synergistically Enhances the Effects of Dendritic Cell Vaccination in a Model of Murine Myeloma

Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma

Efficacy and Safety of Lenalidomide Monotherapy for Relapsed/Refractory Diffuse Large B Cell Lymphoma: Systematic Review and Meta-Analysis